Cepheid (NASDAQ:CPHD) just announced it will be acquired by Danaher (DHR) for $53 per share at a sum of $4 billion in cash. …
In a research report released today, Needham analyst Michael Matson reiterated a Buy rating on shares of MiMedx Group Inc (NASDAQ:MDXG), with a price target …
